People who have genetic variants tied to low production of 25-hydroxyvitamin D (25[OH]D) have an increased risk of hypertension, according to a study published online June 26 in The Lancet Diabetes & Endocrinology.
For patients with ischemic stroke or transient ischemic attack, electrocardiogram (ECG) monitoring with a 30-day event-triggered recorder improves detection of atrial fibrillation, according to a study published June 26 in the New England Journal of Medicine.
Among women with migraines, the frequency of headaches increases during the menopausal transition, according to research presented at the annual meeting of the American Headache Society, held from June 26 to 29 in Los Angeles.
Patients frequently turn to digital media for drug information; however, many Wikipedia entries about medications aren't up-to-date and accurate, according to a perspective piece published in the June 26 issue of the New England Journal of Medicine.
European regulators recently approved alemtuzumab to treat active relapsing-remitting multiple sclerosis, but the US Food and Drug Administration denied the drug for that indication last year.
A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man’s testosterone levels as helping determine sleep quality.
Researchers in Saint Louis are examining the ways in which a drug already approved for multiple sclerosis could ease some of the pain associated with chemotherapy for cancer patients.
Docs might have to wait longer for Medicaid reimbursement, may incur costs for those denied cover
The brains of hyperglycemic patients with Type 1 diabetes produce elevated levels of the neurotransmitter glutamate, which may increase their risk of depression.
Electronic health record-related safety concerns involving both unsafe technology and unsafe use of technology persist long after "go-live," according to a study published online June 20 in the Journal of the American Medical Informatics Association.